期刊文献+

神经酰胺促胃癌SGC7901细胞凋亡的实验 被引量:1

Ceramide Promoting Apoptosis of SGC7901 Cell
下载PDF
导出
摘要 目的探讨神经酰胺(Ceramide,Cer)对胃癌SGC7901细胞的促凋亡作用及可能作用机制。方法体外培养人胃癌SGC7901细胞,分别给予Cer、顺铂(DDP);DDP联合Cer作用后,MTT检测单独使用Cer及联合DDP应用对SGC7901细胞增殖的影响,流式细胞仪检测细胞凋亡率,免疫组织化学染色、Westernblot检测SGC7901细胞NF-κB、Bcl-2、Bax蛋白表达。结果 Cer2.5μmol/L及以上时可以抑制细胞增殖,与对照组相比差异有统计学意义(P<0.05)。Cer联合DDP后,联合用药作用强于单独DDP及Cer组(P<0.05),q值在24、48、72h分别为1.05、1.01、0.99。Cer、DDP作用48h可诱导SGC7901细胞凋亡,Cer5μmol/L、DDP2.5mg/L单独用药组及Cer5μmol/L联合DDP2.5mg/L组凋亡率分别为:(39.23±1.62)%、(47.27±1.13)%、(50.13±2.76)%,与对照组[(18.46±1.64)%]相比差异有统计学意义(P<0.05),联合用药作用强于单独DDP及Cer组(P<0.05)。NF-κB、Bcl-2在SGC7901细胞中较高表达[(74.10±2.69)%、(69.37±4.54)%],Bax在SGC7901细胞中表达较低[(24.60±3.73)%],Cer5μmol/L、DDP2.5mg/L单独用药组及Cer5μmol/L联合DDP2.5mg/L组NF-κB、Bcl-2阳性表达率降低(65.13±1.71、62.17±2.12,44.8±3.65;57.70±2.22、55.13±5.77、37.67±2.14),Bax表达率上调(33.80±1.10、35.50±2.27、51.73±3.76),Bcl-2/Bax比值降低(1.71±0.10、1.56±0.26、0.73±0.09),与对照组相比差别有统计学意义(P<0.05),联合用药作用强于单独DDP及Cer组(P<0.05)。相关性分析显示NF-κB与Bcl-2呈正相关(Spearmansrho=0.9510,Prob>|t|=0.0000)。结论 Cer通过下调NF-κB进而调节Bcl-2/Bax比值诱导SGC7901细胞凋亡。 Objective To investigate the role of ceramide on apoptosis of human gastric cancer SGC7901 cells and its possible mechanism.Methods SGC7901 cells were incubated and treated with the different concentration of ceramide,DDP,DDP in combination with ceramide.Then the inhibitory effect,the apoptosis rate and the expressions of NF-κB,Bcl-2,Bax were detected by MTT assay,flow cytometry,immunocytochemistry staining and western blot assay.Results The proliferation of SGC7901 cells was inhibited by ceramide at the concentration of 2.5 μmol/L compared with control group(P0.05).Ceramide in combination with DDP showed significant differences compared with ceramide and DDP group respectively(P0.05),the q value at 24,48,72h was 1.05,1.01,0.99 respectively.Ceramide,DDP could induce apoptosis of SGC7901,the apoptosis rate of ceramide 5 μmol/L,DDP 2.5 mg/L and Ceramied 5 μmol/L in combination with DDP 2.5 mg/L group were(39.23±1.62)%,(47.27±1.13)%,(50.13±2.76)% respectively,which showed significant difference compared with control group[(18.46±1.64)%](P0.05).Ceramide in combination with DDP showed significant differences compared with ceramide and DDP group respectively(P0.05).The expressions of NF-κB,Bcl-2 were strong in SGC7901[(74.10±2.69)%,(69.37±4.54)%)],while Bax was weak[(24.60±3.73)]%,the expressions of NF-κB,Bcl-2 decreased in Ceramide 5 μmol/L,DDP 2.5 mg/L group and Ceramide 5μmol/L in combination with DDP 2.5 mg/L group(65.13±1.71,62.17±2.12,44.8±3.65;57.70±2.22,55.13±5.77,37.67±2.14),while Bax increased(33.80±1.10,35.50±2.27,51.73±3.76)(P0.05).The ratio of Bcl-2/Bax decreased after treated with ceramide,DDP and ceramide in combination with DDP.There is positive correlation between the expressions of NF-κB and Bcl-2(Spearman's rho =0.9510,Prob |t| =0.0000).Conclusion Ceramide can induce apoptosis by decreasing the expression of NF-κB via changing the ratio of Bcl-2/Bax in gastric cancer SGC7901 cells.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第9期991-994,1065,共5页 Cancer Research on Prevention and Treatment
基金 江苏省教育厅自然科学基金资助项目(05KJD320234) 徐州医学院肿瘤生物治疗重点实验室开放课题资助项目(C0806) 江苏省卫生厅科研课题资助项目(Z201016)
关键词 SGC7901细胞 神经酰胺 核因子ΚB BCL-2 BAX SGC7901 cells Ceramide NF-κB Bcl-2 Bax
  • 相关文献

参考文献20

  • 1Bieberich E. Ceramide signaling in cancer and stem cells [J]. Future Lipidol,2008,3(3) : 273-300.
  • 2Reynolds CP, Maurer BJ, Kolesnick RN. Ceramide synthesis and metabolism as a target for cancer therapy[J].Cancer Lett, 2004,206 (2) : 169-180.
  • 3Park J H, Schuchman EH. Acid Ceramidase and human disease[J].Biochim Biophys Acta,2006,1758(12) :2133 2138.
  • 4Ogretmen B, Hannun YA. Biologically active sphingolipids in cancer pathogenesis and treatment[J]. Nat Rev Cancer,2004, 4(8) :604-616.
  • 5Futerman AH,Hannun YA. The complex life of simple sphin- golipids[J]. EMBO Rep, 2004,5 (8) : 777-782.
  • 6Struckhoff AP,Patel B,Beckman BS. Inhibition of p53 sensiti- zes MCF-7 cells to ceramide treatment[J]. Int J Oncol, 2010, 37(1 ) : 21-30.
  • 7Wang J, Lv X, Shi J, et al. Ceramide induces apoptosis via a peroxisome proliferator-activated receptor gamma-dependent pathway [J]. Apoptosis, 2006, 11 (11) : 2043-2052.
  • 8Modrak DE, Gold DV, Goldenberg DM. Sphingolipid targets in cancer therapy[J]. Mol Cancer Ther, 2006,5 (2) : 200-208.
  • 9Pettus BJ,Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives[J]. Biochim Biophys Acta, 2002,1585(2-3) : 114-125.
  • 10Ji C, Yang B, Yang YL, et al. Exogenous cell-permeable C6 ceramide sensitizes multiple cancer cell lines to Doxorubicin-in- dueed apoptosis by promoting AMPK activation and mTORC1 inhibition[J].Oneogene, 2010,29 (50) : 6557-6568.

同被引文献18

  • 1Andrew R. Rezvani,David G. Maloney.Rituximab resistance[J]. Best Practice & Research Clinical Haematology . 2011 (2)
  • 2Zhao L,Xie F,Li H,et al.Combating non-Hodgkin lymphoma by targeting both CD20and HLA-DR through CD20-243CrossMab. MAbs . 2014
  • 3Tom van Meerten,Anton Hagenbeek.??CD20-Targeted Therapy: The Next Generation of Antibodies(J)Seminars in Hematology . 2010 (2)
  • 4Ronald P. Taylor,Margaret A. Lindorfer.??Antigenic Modulation and Rituximab Resistance(J)Seminars in Hematology . 2010 (2)
  • 5Boppana NB,Kodiha M,Stochaj U,et al.Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carc inoma cel l s af ter Pc4photosensitization. Photochemistry and Photobiology . 2014
  • 6Aluri SR,Shi P,Gustafson JA,et al.A hybrid protein-polymer nanoworm potentiates apoptosis better than a monoclonal antibody. ACS Nano . 2014
  • 7Taniguchi M,Ogiso H,Takeuchi T,et al.Lysosomal ceramide generated by acid sphingomyelinase triggers cytosolic cathepsin B-mediated degradation of X-linked inhibitor of apoptosis protein in natural killer/T lymphoma cell apoptosis. Cell Death Dis . 2015
  • 8Casulo C,Burack WR,Friedberg JW.Transformed follicular non-Hodgkin lymphoma. Blood . 2015
  • 9Drug‐Free Macromolecular Therapeutics: Induction of Apoptosis by Coiled‐Coil‐Mediated Cross‐Linking of Antigens on the Cell Surface(J)Angewandte Chemie International Edition . 2010 (8)
  • 10Ivanov, Andrei,Beers, Stephen A,Walshe, Claire A,Honeychurch, Jamie,Alduaij, Waleed,Cox, Kerry L,Potter, Kathleen N,Murray, Stephen,Chan, Claude H T,Klymenko, Tetyana,Erenpreisa, Jekaterina,Glennie, Martin J,Illidge, Tim M,Cragg, Mark S.??Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells(J)Journal of Clinical Investigation . 2009 (8)

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部